Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Differentiating enantioselective actions of GABOB: a possible role for threonine 244 in the binding site of GABA(C) ρ(1) receptors.
Yamamoto I
,
Absalom N
,
Carland JE
,
Doddareddy MR
,
Gavande N
,
Johnston GA
,
Hanrahan JR
,
Chebib M
.
???displayArticle.abstract???
Designing potent and subtype-selective ligands with therapeutic value requires knowledge about how endogenous ligands interact with their binding site. 4-Amino-3-hydroxybutanoic acid (GABOB) is an endogenous ligand found in the central nervous system in mammals. It is a metabolic product of GABA, the major inhibitory neurotransmitter. Homology modeling of the GABA(C) ρ(1) receptor revealed a potential H-bond interaction between the hydroxyl group of GABOB and threonine 244 (T244) located on loop C of the ligand binding site of the ρ(1) subunit. Using site-directed mutagenesis, we examined the effect of mutating T244 on the efficacy and pharmacology of GABOB and various ligands. It was found that mutating T244 to amino acids that lacked a hydroxyl group in their side chains produced GABA insensitive receptors. Only by mutating ρ(1)T244 to serine (ρ(1)T244S) produced a GABA responsive receptor, albeit 39-fold less sensitive to GABA than ρ(1)wild-type. We also observed changes in the activities of the GABA(C) receptor partial agonists, muscimol and imidazole-4-acetic acid (I4AA). At the concentrations we tested, the partial agonists antagonized GABA-induced currents at ρ(1)T244S mutant receptors (Muscimol: ρ(1)wild-type, EC(50) = 1.4 μM; ρ(1)T244S, IC(50) = 32.8 μM. I4AA: ρ(1)wild-type, EC(50) = 8.6 μM; ρ(1)T244S, IC(50) = 21.4 μM). This indicates that T244 is predominantly involved in channel gating. R-(-)-GABOB and S-(+)-GABOB are full agonists at ρ(1)wild-type receptors. In contrast, R-(-)-GABOB was a weak partial agonist at ρ(1)T244S (1 mM activates 26% of the current produced by GABA EC(50) versus ρ(1)wild-type, EC(50) = 19 μM; I(max) 100%), and S-(+)-GABOB was a competitive antagonist at ρ(1)T244S receptors (ρ(1)wild-type, EC(50) = 45 μM versus ρ(1)T244S, IC(50) = 417.4 μM, K(B) = 204 μM). This highlights that the interaction of GABOB with T244 is enantioselective. In contrast, the potencies of a range of antagonists tested, 3-aminopropyl(methyl)phosphinic acid (3-APMPA), 3-aminopropylphosphonic acid (3-APA), S- and R-(3-amino-2-hydroxypropyl)methylphosphinic acid (S-(-)-CGP44532 and R-(+)-CGP44533), were not altered. This suggests that T244 is not critical for antagonist binding. Receptor gating is dynamic, and this study highlights the role of loop C in agonist-evoked receptor activation, coupling agonist binding to channel gating.
Abdel-Halim,
A molecular basis for agonist and antagonist actions at GABA(C) receptors.
2008, Pubmed
Abdel-Halim,
A molecular basis for agonist and antagonist actions at GABA(C) receptors.
2008,
Pubmed
Adamian,
Structural model of rho1 GABAC receptor based on evolutionary analysis: Testing of predicted protein-protein interactions involved in receptor assembly and function.
2009,
Pubmed
,
Xenbase
Alakuijala,
GABA receptor rho subunit expression in the developing rat brain.
2005,
Pubmed
Amin,
Homomeric rho 1 GABA channels: activation properties and domains.
1994,
Pubmed
,
Xenbase
Arnaud,
Study of a GABAC receptor antagonist on sleep-waking behavior in rats.
2001,
Pubmed
Berman,
The Protein Data Bank.
2000,
Pubmed
Boue-Grabot,
Expression of GABA receptor rho subunits in rat brain.
1998,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Carland,
Charged residues at the 2' position of human GABAC rho 1 receptors invert ion selectivity and influence open state probability.
2004,
Pubmed
Celie,
Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures.
2004,
Pubmed
Chebib,
GABA(C) receptor antagonists differentiate between human rho1 and rho2 receptors expressed in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Chebib,
GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.
2000,
Pubmed
Chebib,
Unsaturated phosphinic analogues of gamma-aminobutyric acid as GABA(C) receptor antagonists.
1997,
Pubmed
,
Xenbase
Chebib,
Analogues of gamma-aminobutyric acid (GABA) and trans-4-aminocrotonic acid (TACA) substituted in the 2 position as GABAC receptor antagonists.
1997,
Pubmed
,
Xenbase
Corringer,
Atomic structure and dynamics of pentameric ligand-gated ion channels: new insight from bacterial homologues.
2010,
Pubmed
Cunha,
GABA(C) Receptors in the Lateral Amygdala: A Possible Novel Target for the Treatment of Fear and Anxiety Disorders?
2010,
Pubmed
Falch,
Comparative stereostructure-activity studies on GABAA and GABAB receptor sites and GABA uptake using rat brain membrane preparations.
1986,
Pubmed
Friesner,
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.
2006,
Pubmed
Froestl,
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
1995,
Pubmed
Gavande,
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology.
2011,
Pubmed
Hansen,
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
2005,
Pubmed
Harrison,
Locating the carboxylate group of GABA in the homomeric rho GABA(A) receptor ligand-binding pocket.
2006,
Pubmed
Hibbs,
Principles of activation and permeation in an anion-selective Cys-loop receptor.
2011,
Pubmed
Hilf,
A prokaryotic perspective on pentameric ligand-gated ion channel structure.
2009,
Pubmed
Hinton,
Enantioselective actions of 4-amino-3-hydroxybutanoic acid and (3-amino-2-hydroxypropyl)methylphosphinic acid at recombinant GABA(C) receptors.
2008,
Pubmed
,
Xenbase
Johnston,
GABAc receptors: relatively simple transmitter -gated ion channels?
1996,
Pubmed
Johnston,
GABAA receptor pharmacology.
1996,
Pubmed
Johnston,
Medicinal chemistry and molecular pharmacology of GABA(C) receptors.
2002,
Pubmed
Krogsgaard-Larsen,
GABA agonists. Resolution, absolute stereochemistry, and enantioselectivity of (S)-(+)- and (R)-(-)-dihydromuscimol.
1985,
Pubmed
Mercklé,
A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
2005,
Pubmed
Miller,
Binding, activation and modulation of Cys-loop receptors.
2010,
Pubmed
Nakao,
Formation of GABOB from 2-hydroxyputrescine and its anticonvulsant effect.
1991,
Pubmed
Noto,
Formation of gamma-amino-beta-hydroxybutyric acid from 2-hydroxyputrescine in rat brain.
1988,
Pubmed
Noto,
Assay of 2-hydroxyputrescine in various regions of rat brain by gas chromatography-mass spectrometry.
1988,
Pubmed
Ong,
Comparative activities of the enantiomeric GABA(B) receptor agonists CGP 44532 and 44533 in central and peripheral tissues.
2001,
Pubmed
Ortells,
Evolutionary history of the ligand-gated ion-channel superfamily of receptors.
1995,
Pubmed
Purohit,
Acetylcholine receptor gating: movement in the alpha-subunit extracellular domain.
2007,
Pubmed
Purohit,
A stepwise mechanism for acetylcholine receptor channel gating.
2007,
Pubmed
Roberts,
Different efficacies of d- and l-gamma-amino-beta-hydroxybutyric acids in GABA receptor and transport test systems.
1981,
Pubmed
Rozzo,
Expression and dendritic mRNA localization of GABAC receptor rho1 and rho2 subunits in developing rat brain and spinal cord.
2002,
Pubmed
Stone,
GABA, experimental myopia, and ocular growth in chick.
2003,
Pubmed
Thompson,
The structural basis of function in Cys-loop receptors.
2010,
Pubmed
Xie,
2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-ρ1 receptors.
2011,
Pubmed
,
Xenbase
Yamamoto,
Agonist responses of (R)- and (S)-3-fluoro-γ-aminobutyric acids suggest an enantiomeric fold for GABA binding to GABA(C) receptors.
2011,
Pubmed
Zhang,
Structural determinants for antagonist pharmacology that distinguish the rho1 GABAC receptor from GABAA receptors.
2008,
Pubmed
,
Xenbase